CPC Biotech is making waves in the biopharmaceutical industry with the introduction of its unified bioprocess fluid portfolio. This venture consolidates the strengths of CPC’s Biopharma connector products and PSG Biotech’s expertise in pump, flow meter, and sensor technologies. Together, they aim to deliver an integrated solution that enhances fluid management for biopharmaceutical applications.
Debuting at INTERPHEX 2026
The official unveiling of CPC Biotech will take place at INTERPHEX 2026, from April 21 to 23 at the Jacob K. Javits Convention Center in New York City. Attendees can visit Booth #3129 to explore the complete range of products and engage with the CPC Biotech team.
Uniting Expertise for Innovation
This launch marks a significant step in bioprocessing fluid management, combining the decades of experience from two industry leaders. CPC has established itself as a trusted name in single-use sterile and quick connect technologies. In parallel, PSG Biotech has built a strong reputation for its reliable low-shear pumps and precision flow meters and sensors, essential for bioprocessing applications globally.
CPC Biotech’s strategy is to leverage this combined expertise to enhance the fluid path, driven by customer collaboration and feedback.
A Statement from Leadership
John Boehm, General Manager of CPC Biotech, expressed enthusiasm about the new brand’s formation. He stated, “We are thrilled to be combining our best-in-class critical fluid management technologies for the biopharma industry under one new global brand, CPC Biotech. By bringing together our global team of experts across various fields, we will drive increased innovation to better serve our customers and help advance the biopharma industry.”
Comprehensive Product Offering
CPC Biotech’s portfolio is structured around three core categories that facilitate the connection, movement, and measurement of critical biopharmaceutical fluids:
- BioPro Clamp-On Ultrasonic Flow Sensors
- BioPro FlowSU Inline Ultrasonic Flow Sensors
These products are tailored for critical applications, ensuring reliability and performance throughout the bioprocessing workflow.
Supporting Bioprocessing Applications
The solutions provided by CPC Biotech encompass a wide array of bioprocessing needs, covering both upstream and downstream stages of biologic drug manufacturing as well as cell and gene therapy production. The commitment to delivering dependable flow management solutions is evident in the design and manufacturing of these products.
CPC Biotech’s manufacturing facilities span North America, Europe, and Asia, ensuring that their products meet rigorous quality standards. The company supports a global network, serving customers in over 50 countries through a well-established channel partner system, all under the auspices of Dover Corporation’s extensive resources.
Experience at INTERPHEX 2026
INTERPHEX 2026 will provide the first opportunity for biopharma professionals to engage with the complete CPC Biotech portfolio. Attendees are encouraged to visit Booth #3129 for live product demonstrations and direct discussions with technical experts about their specific application needs.
Leading the Way in Bioprocessing
CPC Biotech stands at the forefront of bioprocessing fluid management and flow control, offering a comprehensive array of components, including connectors, pumps, flow meters, and sensors. These industry-leading products empower biopharma innovators to develop next-generation biologics and therapeutics with optimal integrity, yield, efficiency, and scalability. From laboratory settings to commercial launch, CPC Biotech is committed to facilitating breakthroughs in medicine and biologics that enhance lives and advance humanity.
The PSG Connection
PSG, as an operating company within Dover Corporation, brings extensive knowledge in pump, metering, connector, and dispensing solutions, ensuring the safe and efficient transfer of critical fluids. Their flow meters are designed to minimize waste and downtime while accurately measuring and controlling fluid distribution. Headquartered in Downers Grove, Illinois, PSG encompasses several prominent brands, all dedicated to excellence in manufacturing and operational efficiency.
Summary
CPC Biotech’s launch of its unified bioprocess fluid portfolio signifies a transformative moment in the biopharmaceutical landscape. By harnessing the strengths of both CPC and PSG Biotech, the company is set to redefine fluid management in bioprocessing.
- Key Takeaways:
- CPC Biotech merges expertise from two industry leaders.
- The product range includes advanced flow sensors and management solutions.
- The brand will debut at INTERPHEX 2026, showcasing innovations to biopharma professionals.
- Manufacturing spans multiple continents, ensuring global support and quality.
- The focus remains on enhancing the efficiency and reliability of biopharmaceutical processes.
In conclusion, CPC Biotech’s strategic unification and product launch present a promising advancement for the biopharmaceutical industry, aiming to streamline fluid management and facilitate innovative therapeutic developments.
Read more → www.medicaldesignandoutsourcing.com